EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Head-To-Head Contrast: Synlogic (NASDAQ:SYBX) versus Novavax (NASDAQ:NVAX)
Assessing Novavax (NVAX) Valuation After Recent Share Price Volatility And Licensing Expectations
Chandrakant Lahariya | Flu-COVID Combo Vaccines: An Idea Whose Time Has Not Yet Arrived
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts
Is It Time To Reassess Novavax (NVAX) After Recent Volatility And Partnership News
Is Novavax (NVAX) Being Pulled Between R&D Ambitions and Activist Demands for Discipline? - Simply Wall St News
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians
Assessing Novavax (NVAX) Valuation After Renewed Focus On Covid And Malaria Vaccine Deals
Shah Capital intends to vote against Novavax's board nominees, executive compensation
Is Novavax (NVAX) A Potential Opportunity After Recent Share Price Weakness
Assessing Novavax (NVAX) Valuation After Recent Share Price Swings And Royalty Deal Outlook
Traders Buy Large Volume of Call Options on Novavax (NASDAQ:NVAX)
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
Will Novavax's New R&D Chief Reframe Its Partnership-Led Strategy and Long-Term Story (NVAX)? - Simply Wall St News
Novavax (NASDAQ:NVAX) Shares Down 5.4% - Should You Sell? - Daily Political
Novavax (NASDAQ:NVAX) Shares Pass Above Two Hundred Day Moving Average - Should You Sell? - Stock Observer
2 Growth Stocks Set to Flourishand 1 We Question
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving Average - Here's Why
Shah Capital Management Purchases 2,747,000 Shares of Novavax, Inc. $NVAX - Daily Political
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
A Look Back at Biotechnology Stocks' Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
Evaluating Novavax (NVAX) Valuation As Licensing Deal And Recent Returns Shape Market Expectations
3 Stocks Under $50 That Concern Us
Novavax, Inc. (NASDAQ:NVAX) Receives $11.88 Average Target Price from Analysts - Markets Daily
Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks
Q3 Earnings Forecast for Novavax Issued By Zacks Research
Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
Q3 Earnings Estimate for Novavax Issued By Zacks Research
Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations
Novavax News
Market Resilience Amidst Geopolitical Tensions: HSBC's Optimistic Strategic Outlook
Kuwait Declares Force Majeure on Oil Shipments Amidst Strait of Hormuz Blockade: Impacts and Recovery Outlook
Iran's Uranium Transfer: Navigating Complex Logistics and Diplomatic Hurdles
Bank of Japan Leans Towards Keeping Rates Unchanged Amid Middle East Conflict Uncertainty
Latest 22K Gold Price per Gram in Dubai: How Much is 22K Gold in Dubai Right Now?
Lowest Cost CFD Brokers in Dubai (2026): Fusion Markets, Pepperstone, Capital.com and More
Top 5 Bitcoin Brokers in South Africa for 2026: Binance, VALR, Luno and More
Latest news
Show moreHormuz Strait: The Flashpoint in US-Iran Talks and Persian Gulf Concerns
Fed Nominee Kevin Warsh Emphasizes Central Bank's Role and Independence at Crucial Economic Juncture
Geopolitical Tweets Reshape Oil Markets: Citadel's Insights on Navigating Trump-Era Volatility
Poland's Defense Funding Debate: EU Loans vs. Central Bank Gold Reserves
Hormuz Strait Tensions Reignite Market Volatility and Economic Concerns
Iran Conflict Sparks US Inflationary Surge, With Lingering Economic Repercussions
